Biotest vz. Aktie
30,00EUR | 0,00EUR | 0,00% |
WKN: 522723 / ISIN: DE0005227235
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 1 928 | 1 967 | 2 228 | 2 426 | 2 495 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,25 | 0,26 | 0,23 | 0,28 | 0,29 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 556 | 522 | 619 | 757 | 810 |
Summe Anlagevermögen | 604 | 609 | 612 | 688 | 635 |
Summe Aktiva | 1 161 | 1 131 | 1 232 | 1 444 | 1 444 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 719 | 751 | 861 | 945 | 914 |
Summe Eigenkapital | 442 | 380 | 371 | 499 | 531 |
Summe Passiva | 1 161 | 1 131 | 1 232 | 1 444 | 1 444 |
Adresse
Landsteinerstrasse 5, 63303 Dreieich | |
Telefon | +49 (6103) 801-0 |
Fax | +49 (6103) 801-150 |
Internet | http://www.biotest.de |
Management
Bernhard R. M. Ehmer
Chairman-Supervisory Board |
Christian Polus
Head-Information Technology |
Christina Erb
Head-Human Resources |
David Ian Bell
Member-Supervisory Board |
Dirk Schuck
Member-Supervisory Board |
Enrico D'Aiuto
Head-Marketing & Sales |
Josefine Buth
Head-Regulatory Affairs |
Jürgen Heilmann
Member-Supervisory Board |
Monika Buttkereit
Head-Investor Relations |
Oliver Hein
Head-Risk & Compliance |
Peter Janssen
Chairman-Management Board |
Raimon Grifols Roura
Member-Supervisory Board |
Stephan Fleck
Head-Controlling |
Tomás Dagá Gelabert
Vice Chairman-Supervisory Board |